Cargando…
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and premature death. However, the wide phenotypic hetero...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321861/ https://www.ncbi.nlm.nih.gov/pubmed/35885941 http://dx.doi.org/10.3390/genes13071158 |
_version_ | 1784756152371773440 |
---|---|
author | Berta, Eszter Zsíros, Noémi Bodor, Miklós Balogh, István Lőrincz, Hajnalka Paragh, György Harangi, Mariann |
author_facet | Berta, Eszter Zsíros, Noémi Bodor, Miklós Balogh, István Lőrincz, Hajnalka Paragh, György Harangi, Mariann |
author_sort | Berta, Eszter |
collection | PubMed |
description | Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and premature death. However, the wide phenotypic heterogeneity in FH makes the cardiovascular risk prediction challenging in clinical practice to determine optimal therapeutic strategy. Beyond the lifetime LDL-C vascular accumulation, other genetic and non-genetic risk factors might exacerbate CVD development. Besides the most frequent variants of three genes (LDL-R, APOB, and PCSK9) in some proband variants of other genes implicated in lipid metabolism and atherogenesis are responsible for FH phenotype. Furthermore, non-genetic factors, including traditional cardiovascular risk factors, metabolic and endocrine disorders might also worsen risk profile. Although some were extensively studied previously, others, such as common endocrine disorders including thyroid disorders or polycystic ovary syndrome are not widely evaluated in FH. In this review, we summarize the most important genetic and non-genetic factors that might affect the risk prediction and therapeutic strategy in FH through the eyes of clinicians focusing on disorders that might not be in the center of FH research. The review highlights the complexity of FH care and the need of an interdisciplinary attitude to find the best therapeutic approach in FH patients. |
format | Online Article Text |
id | pubmed-9321861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93218612022-07-27 Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia Berta, Eszter Zsíros, Noémi Bodor, Miklós Balogh, István Lőrincz, Hajnalka Paragh, György Harangi, Mariann Genes (Basel) Review Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and premature death. However, the wide phenotypic heterogeneity in FH makes the cardiovascular risk prediction challenging in clinical practice to determine optimal therapeutic strategy. Beyond the lifetime LDL-C vascular accumulation, other genetic and non-genetic risk factors might exacerbate CVD development. Besides the most frequent variants of three genes (LDL-R, APOB, and PCSK9) in some proband variants of other genes implicated in lipid metabolism and atherogenesis are responsible for FH phenotype. Furthermore, non-genetic factors, including traditional cardiovascular risk factors, metabolic and endocrine disorders might also worsen risk profile. Although some were extensively studied previously, others, such as common endocrine disorders including thyroid disorders or polycystic ovary syndrome are not widely evaluated in FH. In this review, we summarize the most important genetic and non-genetic factors that might affect the risk prediction and therapeutic strategy in FH through the eyes of clinicians focusing on disorders that might not be in the center of FH research. The review highlights the complexity of FH care and the need of an interdisciplinary attitude to find the best therapeutic approach in FH patients. MDPI 2022-06-27 /pmc/articles/PMC9321861/ /pubmed/35885941 http://dx.doi.org/10.3390/genes13071158 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Berta, Eszter Zsíros, Noémi Bodor, Miklós Balogh, István Lőrincz, Hajnalka Paragh, György Harangi, Mariann Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title_full | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title_fullStr | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title_full_unstemmed | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title_short | Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia |
title_sort | clinical aspects of genetic and non-genetic cardiovascular risk factors in familial hypercholesterolemia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321861/ https://www.ncbi.nlm.nih.gov/pubmed/35885941 http://dx.doi.org/10.3390/genes13071158 |
work_keys_str_mv | AT bertaeszter clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT zsirosnoemi clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT bodormiklos clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT baloghistvan clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT lorinczhajnalka clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT paraghgyorgy clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia AT harangimariann clinicalaspectsofgeneticandnongeneticcardiovascularriskfactorsinfamilialhypercholesterolemia |